Compare Johnson & Johnson (JNJ) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Kraft Heinz Co — how do they compare? Johnson & Johnson trades at $260.51 (market cap $626.09B), while Kraft Heinz Co trades at $24.59 (market cap $29.23B). The key difference: Johnson & Johnson is far larger — about 21.4× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (6.49%). Which is the better fit depends on your goals.
| JNJ | KHC | |
|---|---|---|
Market Cap | $626.09B | $29.23B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Staples |
52-Week High | $267.24 | $28.06 |
52-Week Low | $172.78 | $21.21 |
Enterprise Value | $654.37B | $45.55B |
Dividend Yield | 2.06% | 6.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Kraft Heinz (KHC) trades at $24.48, down 1.81% on the day, with a bearish technical signal and mixed sentiment. The stock shows attractive valuation ratios like a P/E of 13.04 and P/B of 0.81, but fundamentals are pressured by a net loss of $5.85 billion in 2025 and negative profit margins. Recent quarters have beaten EPS estimates, and the company maintains a $0.40 quarterly dividend, though dividend sustainability concerns persist amid earnings erosion.
The outlook is cautious; while the stock appears undervalued and dividend yield is high, ongoing profit declines and sector headwinds pose risks. Analyst consensus is mixed with a $24 price target, and institutional selling adds pressure. Key catalysts include the success of CEO Cahillane's turnaround strategy, but execution risks and competitive threats remain significant hurdles for shareholder value recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
